Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Tao Shan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6680-9302; OpenAlex author ID A5101707183. Sources: OpenAlex.

Their work

Papers
14 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
38
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 1 paper · 2014: 1 paper · 2015: none · 2016: 3 papers · 2017: 2 papers · 2018: 2 papers · 2019: none · 2020: 2 papers · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper

Papers 14

  1. MiR-21-mediated Metabolic Alteration of Cancer-associated Fibroblasts and Its Effect on Pancreatic Cancer Cell Behavior: Retraction. Co-author DOI 10.7150/ijbs.91613↗
  2. Conversion of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition is mediated by oxygen concentration in pancreatic cancer cells. Co-author DOI 10.3892/ol.2022.13227↗
  3. Magnolol Suppresses Pancreatic Cancer Development In Vivo and In Vitro via Negatively Regulating TGF-β/Smad Signaling. Co-author DOI 10.3389/fonc.2020.597672↗
  4. MicroRNA-4516 suppresses pancreatic cancer development via negatively regulating orthodenticle homeobox 1. Last author DOI 10.7150/ijbs.45933↗
  5. Conversion of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition is mediated by oxygen concentration in pancreatic cancer cells. Co-author DOI 10.3892/ol.2018.8219↗
  6. MiR-21-mediated Metabolic Alteration of Cancer-associated Fibroblasts and Its Effect on Pancreatic Cancer Cell Behavior. Co-author DOI 10.7150/ijbs.22555↗
  7. Prometastatic mechanisms of CAF-mediated EMT regulation in pancreatic cancer cells. Co-author DOI 10.3892/ijo.2016.3779↗
  8. Cancer-associated fibroblasts enhance pancreatic cancer cell invasion by remodeling the metabolic conversion mechanism. Co-author DOI 10.3892/or.2017.5479↗
  9. Reactive Oxygen Species and Targeted Therapy for Pancreatic Cancer. Co-author DOI 10.1155/2016/1616781↗
  10. The Relevance of Nrf2 Pathway and Autophagy in Pancreatic Cancer Cells upon Stimulation of Reactive Oxygen Species. Co-author DOI 10.1155/2016/3897250↗
  11. Lipoxin A4 Attenuates Cell Invasion by Inhibiting ROS/ERK/MMP Pathway in Pancreatic Cancer. Co-author DOI 10.1155/2016/6815727↗
  12. Loss of stromal caveolin-1 expression: a novel tumor microenvironment biomarker that can predict poor clinical outcomes for pancreatic cancer. Co-author DOI 10.1371/journal.pone.0097239↗
  13. Interaction of the sympathetic nerve with pancreatic cancer cells promotes perineural invasion through the activation of STAT3 signaling. Co-author DOI 10.1158/1535-7163.mct-12-0809↗
  14. β2-adrenoceptor blocker synergizes with gemcitabine to inhibit the proliferation of pancreatic cancer cells via apoptosis induction. Co-author DOI 10.1016/j.ejphar.2011.04.055↗

Closest collaborators

The 25 strongest of 38 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ya’an Kang · 6 shared papers, 2017–2024 · strength 0.68
  2. Shuo Chen · 5 shared papers, 2017–2024 · strength 0.61
  3. Gang Cao · 4 shared papers, 2018–2022 · strength 0.43
  4. Shuo Chen · 3 shared papers, 2017–2022 · strength 0.28
  5. Qingyong Ma · 5 shared papers, 2011–2016 · strength 0.22
  6. Wenbin Yang · 2 shared papers, 2018–2022 · strength 0.21
  7. Jiaqi Shen · 2 shared papers, 2020 · strength 0.21
  8. Hong Long Ji · 3 shared papers, 2014–2017 · strength 0.18
  9. Wěi Li · 2 shared papers, 2017–2018 · strength 0.16
  10. Wei Li · 3 shared papers, 2016 · strength 0.15
  11. Liang Zong · 3 shared papers, 2016 · strength 0.15
  12. Lun Zhang · 3 shared papers, 2016 · strength 0.15
  13. Xuqi Li · 3 shared papers, 2016 · strength 0.15
  14. Junhui Li · 2 shared papers, 2013–2020 · strength 0.15
  15. Xi Chen · 2 shared papers, 2017–2018 · strength 0.14
  16. Qinhong Xu · 3 shared papers, 2013–2016 · strength 0.14
  17. Tao Wu · 2 shared papers, 2014–2017 · strength 0.11
  18. Yang Liu · 1 shared paper, 2020 · strength 0.11
  19. Zhengdong Jiang · 2 shared papers, 2016 · strength 0.10
  20. Jiahui Li · 2 shared papers, 2016 · strength 0.10
  21. Jianjun Lei · 2 shared papers, 2016 · strength 0.10
  22. Wanxing Duan · 2 shared papers, 2016 · strength 0.10
  23. Wei Li · 1 shared paper, 2018 · strength 0.07
  24. Li Wang · 1 shared paper, 2018 · strength 0.07
  25. Wei Li · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.